Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Interleukin-2 receptor-directed therapies: antibody-or cytokine-based targeting molecules.

Interleukin-2 receptor-directed therapies: antibody-or cytokine-based targeting molecules. Annu Rev Med. 1993; 44:343-53.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.